Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.

Journal of hepatology - 1 Jan 2022

Björnsson Helgi Kristinn, Gudbjornsson Bjorn, Björnsson Einar Stefan

Abstract excerpt

BACKGROUND & AIMS: Infliximab has been associated with drug-induced liver injury (DILI), particularly drug-induced autoimmune hepatitis (DIAIH). DIAIH is commonly treated with corticosteroids, but there is limited data on the efficacy of corticosteroids in infliximab-induced DILI. METHODS: Patients were included for assessment if they had been treated with infliximab between 2009-2020 in Iceland and had developed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Phenotype
Share to Adrenal Cortex Hormones
Share to Autoimmunity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemical and Drug Induced Liver Injury

Share to Iceland

Share to Infliximab

Source

Identifiers

PMID: 34487751
DOI: 10.1016/j.jhep.2021.08.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.PMID 34487751Read ↗

Prednisolone Therapy Accelerated Recovery of Severe Drug-Induced Liver Injury: A Prospective Randomized Controlled StudySemantic proximity Read ↗

Autoimmune hepatitis.Semantic proximity Read ↗

Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead.Semantic proximity Read ↗

Recent advances in clinical practice: epidemiology of autoimmune liver diseases.Semantic proximity Read ↗

The clinical phenotypes of autoimmune hepatitis: A comprehensive review.Semantic proximity Read ↗

Idiosyncratic drug-induced liver injury: an update on the 2007 overview.Semantic proximity Read ↗

Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Semantic proximity Read ↗

Case definition and phenotype standardization in drug-induced liver injury.Semantic proximity Read ↗

Autoimmune hepatitis.Semantic proximity Read ↗

Idiopathic or Drug Induced Autoimmune HepatitisCan We Draw a Line?Semantic proximity Read ↗

Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.Semantic proximity Read ↗

Cutting edge issues in autoimmune hepatitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.